CWA Asset Management »

Cognition Therapeutics shares owned by CWA Asset Management

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by CWA Asset Management from 13F filings

Historical chart of CWA Asset Management investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by CWA Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by CWA Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $34k 25k 1.35

More positions owned by CWA Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Capitol Ser Tr Sterling Cap Enh (SCEC)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Orla Mining LTD New F (ORLA)
Costco Wholesale Corporation (COST)
Franco-Nevada Corporation (FNV)

View all positions for CWA Asset Management

Top funds holding Cognition Therapeutics

BIOS Capital Management
Davenport & Co
Vanguard Group
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
American Financial Group

View all funds holding Cognition Therapeutics